Legislative Observatory
European Parliament
Please fill in this field to find a procedure

2017/0340(NLE)

Subjecting the new psychoactive substance N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-(cyclohexylmethyl)-1H-indazole-3-carboxamide (ADB-CHMINACA) to control measures

Basic information

2017/0340(NLE)

NLE - Non-legislative enactments

Subject

7.30.30.04 Action to combat drugs and drug-trafficking

Status

Procedure completed

Please go to Documentation gateway for any follow-up documents.

Key players

Key events

Date Event Reference Summary
18/12/2017 Preparatory document COM(2017)0757
02/02/2018 Legislative proposal published 05387/2018
28/02/2018 Committee referral announced in Parliament
27/03/2018 Vote in committee
04/04/2018 Committee report tabled for plenary, 1st reading/single reading A8-0133/2018
03/05/2018 Decision by Parliament T8-0193/2018
03/05/2018 Results of vote in Parliament
14/05/2018 Act adopted by Council after consultation of Parliament
14/05/2018 End of procedure in Parliament
22/05/2018 Final act published in Official Journal

Technical information

Procedure Information
Procedure reference 2017/0340(NLE)
Procedure type NLE - Non-legislative enactments
Nature of procedure Consent by Parliament
Other legal basis Rules of Procedure EP 165
Stage reached in procedure Procedure completed
Committee dossier LIBE/8/11876

Documentation gateway

  • Document type Committee Reference Date Summary
    Committee draft report PE618.023 14/02/2018
    Committee report tabled for plenary, 1st reading/single reading A8-0133/2018 04/04/2018
    Text adopted by Parliament, 1st reading/single reading T8-0193/2018 03/05/2018
  • Document type Reference Date Summary
    Legislative proposal 05387/2018 02/02/2018
  • Document type Reference Date Summary
    Preparatory document COM(2017)0757 18/12/2017

Final act